Research Corporation stake in Hofseth BioCare falls below 5% after tranche 2 registration

The change followed registration on August 6, 2026 of HBC's tranche 2 offer-share capital increase, leaving Research Corporation Pty Ltd. with 24,280,748 ordinary shares and 4.80% of voting rights.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.